A two-stage neural network fusion system from Romanian researchers achieved 93.53% F1 score in segmenting ovarian tumors from ...

New research shows that blocking the CXCL12/CXCR4 signaling axis in ovarian cancer cells produces a paradoxical biphasic ...

Compugen (NASDAQ:CGEN) outlined the clinical rationale for its COM701 antibody in platinum-sensitive ovarian cancer and ...

The immune system is a major determinant of how patients respond to standard treatments for ovarian cancer, the leading cause of death from gynecological malignancies. But little was known about how ...

Cancer that develops in the ovaries (the egg-producing reproductive organs) is referred to as ovarian cancer. There are three types of ovarian cancer. Each type has differences in how they will ...

Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary tumors in the abdominal cavity at the time of diagnosis. These metastases are ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases including recurrent and metastatic cancer, ...

Learn how Anixa is advancing two clinical-stage oncology programs through differentiated immunotherapy and vaccine ...

At 92, Miriam Feder has found yet another purpose in life. The Brooklyn-born Eldorado resident has devoted herself to plenty ...

A study published in Science Advances shows that OMTX305, an antibody designed by Oncomatryx, destroyed the fibroblasts that protect the tumor in t ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in differentiated targeted radiotherapies with the potential to transform cancer treatment, today announced ...

A woman in her 50s who thought a contraceptive device was causing her abdominal pain was found to have a 13-centimeter tumor ...